TXMD
TherapeuticsMD, Inc.
NASDAQ · Healthcare
| Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | |||||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — | — | — |
| Investing | |||||||||||
| Capital Expenditures | 34,000 | 207,000 | 2.5M | 217,040 | 61,817 | 396,154 | 165,257 | 30,962 | 40,790 | 66,405 | 28,766 |
| Acquisitions | — | — | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing | |||||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — | — | — |
| Summary | |||||||||||
| Free Cash Flow | -142.7M | -159.7M | -168.2M | -107.0M | -76.2M | -69.5M | -79.2M | -45.6M | -20.8M | -12.8M | -5.0M |
| Net Change in Cash | — | — | — | — | — | — | — | — | — | — | — |